Diabetes-induced albuminuria: Role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats

Nephrology Dialysis Transplantation

Volumn 18, Issue 9, 2003, Pages 1755-1763

  Bardoux, Pascale ^a   Bruneval, Patrick ^b   Heudes, Didier ^b   Bouby, Nadine ^a   Bankir, Lise ^a  

^a INSTITUT DU FER À MOULIN   (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

Diabetes mellitus; Free water clearance; Glomerural filtration rate; Mesangium; Urinary albumin excretion; Vasopressin

Indexed keywords

ALBUMIN; CREATININE; N TERT BUTYL 4 [5' ETHOXY 4 (2 MORPHOLINOETHOXY) 2' OXOSPIRO[CYCLOHEXANE 1,3' INDOLE] 1' SULFONYL] 3 METHOXYBENZAMIDE; STREPTOZOCIN; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE PREDISPOSITION; DOSE RESPONSE; GLOMERULUS FILTRATION RATE; HORMONE ACTION; KIDNEY CONCENTRATING CAPACITY; MALE; MESANGIUM; NONHUMAN; PLASMA OSMOLALITY; PRIORITY JOURNAL; PROTEINURIA; RAT; STREPTOZOCIN DIABETES; URINALYSIS; URINE OSMOLALITY;

ALBUMINURIA; ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; KIDNEY; MALE; MORPHOLINES; RATS; RATS, WISTAR; RECEPTORS, VASOPRESSIN; SPIRO COMPOUNDS; STREPTOZOCIN; VASOPRESSINS;

EID: 0041883699     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg277     Document Type: Article

References (25)

1. Zerbe RL, Vinicor F, Robertson GL. Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 1979; 28: 503-508
2. Bankir L, Bardoux P, Ahloulay M. Vasopressin and diabetes mellitus. Nephron 2001; 87: 8-18
3. Ahloulay M, Schmitt F, Dechaux M, Bankir L. Vasopressin and urinary concentrating activity in diabetes mellitus. Diabetes Metab 1999; 25: 213-222
4. Bardoux P, Martin H, Ahloulay M et al. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Proc Natl Acad Sci USA 1999; 96: 10397-10402
5. Bouby N, Ahloulay M, Nsegbe E, Dechaux M, Schmitt F, Bankir L. Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action. J Am Soc Nephrol 1996; 7: 842-851
6. Bouby N, Bachmann S, Bichet D, Bankir L. Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am J Physiol 1990; 258: F973-F979
7. Sugiura T, Yamauchi A, Kitamura H et al. High water intake ameliorates tubulointerstitial injury in rats with subtotal nephrectomy: possible role of TGF-β. Kidney Int 1999; 55: 1800-1810
8. Bouby N, Hassler C, Bankir L. Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats. Life Sci 1999; 65: 991-1004
9. Bardoux P, Bichet DG, Martin H et al. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. Nephrol Dial Transplant 2003; 18: 497-506
10. Heudes D, Michel O, Chevalier J et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function. Am J Physiol 1994; 266: R1038-R1051
11. Bankir L. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects [Review]. Cardiovasc Res 2001; 51: 372-390
12. 2-mediated water reabsorption in Brattleboro rats with diabetes insipidus. Nephrol Dial Transplant2001; 16:725-734
13. Bankir L, Trinh-Trang-Tan MM. Urea and the kidney. In: Brenner BM, ed. The Kidney, 6th edn. WB Saunders Co., Philadelphia, 2000: 637-679
14. Hadj-Aissa A, Bankir L, Fraysse M et al. Influence of the level of hydration on the renal response to a protein meal. Kidney Int 1992; 42: 1207-1216
15. Bankir L, Kriz W. Adaptation of the kidney to protein intake and to urine concentrating activity: similar consequences in health and CRF [Editorial Review]. Kidney Int 1995; 47: 7-24
16. Pozet N, Labeeuw M, Kaffa I et al. Clairance de la créatinine à débit urinaire faible. Nephrologie 1985; 6: 78
17. Sjostrom PA, Odlind BG, Wolgast M. Extensive tubular secretion and reabsorption of creatinine in humans. Scand J Urol Nephrol 1988; 22: 129-131
18. Okada H, Suzuki H, Kanno Y, Yamamura Y, Saruta T. Effects of vasopressin V1 and V2. receptor antagonists on progressive renal failure in rats. Clin Sci 1994; 86: 399-404
19. Terada Y, Tomita K, Nonoguchi H, Yang T, Marumo F. Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction. J Clin Invest 1993; 92: 2339-2345
20. Ohnishi A, Orita Y, Takagi N et al. Aquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men. J Pharmacol Exp Ther 1995; 272: 546-551
21. Burnier M, Fricker AF, Hayoz D, Nussberger J, Brunner HR. Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2 vasopressin receptor antagonist in normal subjects. Eur J Clin Pharmacol 1999; 55: 633-637
22. Gekle M. Renal proximal tubular albumin reabsorption: daily prevention of albuminuria. News Physiol Sci 1998; 13: 5-11
23. Tojo A, Endou H. Intrarenal handling of proteins in rats using fractional micropuncture technique. Am J Physiol 1992; 263: F601-F606
24. Marre M, Hadjadj S, Bouhanick B. Genetics and diabetic nephropathy. In: Mogensen CE, ed. The Kidney and Hypertension in Diabetes Mellitus. Kluwer, Boston/Dordrecht/London, 2000: 115-128
25. Osterby R. Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 1992; 35: 803-812